Related Experiment Videos
Evaluation of scoring systems in acute meningococcaemia
S Hachimi-Idrissi1, L Corne, J Ramet
1Paediatric Emergency Department, University Hospital of the Free University Brussels (AZ-VUB), Belgium.
Summary
Accurate prediction of severe meningococcal infections is crucial. The Algren criteria showed better accuracy than GMSPS and NESI scores in predicting outcomes for pediatric meningococcemia patients.
Area of Science:
- Pediatrics
- Infectious Diseases
- Critical Care Medicine
Background:
- Acute meningococcal infections can lead to life-threatening complications requiring prompt recognition and monitoring.
- Several prognostic scoring systems exist to aid in predicting outcomes for patients with meningococcal disease.
Purpose of the Study:
- To compare the bedside availability and prognostic significance of three scoring systems: Glasgow meningococcal sepsis prognostic score (GMSPS), Neisseria sepsis index (NESI), and Algren criteria.
- To evaluate the accuracy of these scoring systems in predicting outcomes in pediatric patients with meningococcemia.
Main Methods:
- Retrospective analysis of 20 consecutive pediatric patients with proven meningococcal infection admitted to a pediatric intensive care unit.
- Calculation and evaluation of GMSPS, NESI, and Algren criteria based on clinical and biological data collected upon admission.
Main Results:
- All three scoring systems predicted death in the four non-surviving patients.
- The Algren criteria demonstrated higher accuracy in predicting clinical severity compared to GMSPS and NESI.
- GMSPS, NESI, and Algren criteria falsely predicted death in 6, 5, and 1 patient(s), respectively.
Conclusions:
- While the Algren criteria showed better predictive accuracy, caution is advised when making critical therapeutic or ethical decisions based solely on these scoring systems due to their limitations in precision.
- These scoring systems may assist in decision-making regarding patient transfer, intensive care monitoring, and consideration of novel therapies for meningococcal infections.